Medicare Weighing Higher Add-On Payments For New Drugs, Including CAR-T

 
• By Cathy Kelly

Change would increase maximum new technology add-on payments from 50% to 65% of costs.

3D illustration of T cells attacking a cancer cell (CAR-T cell therapy) - Illustration

More from Market Access

More from Pink Sheet